Heat shock protein 70 alters the endosome-lysosomal localization of huntingtin

Experimental and Molecular Medicine

Volumn 39, Issue 1, 2007, Pages 38-46

  Bong, Sun Kang ^a   Ahn, Jin Young ^b   Min, Ky Kim ^b   Kim, Hyun Jeong ^a   Kang, Lami ^a   Lim, Hun Chang ^e   Park, Kyung Sook ^c   Lee, Jae Seon ^d   Seo, Jeong Sun ^d   Choong, Ik Cha ^e   Kim, Seung U ^f,g   Yoon, Jeong Park ^d   Kim, Manho ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul Medical Center   (South Korea)

^c Sungshin Women's University   (South Korea)

^d Seoul National University   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

^f Ajou University   (South Korea)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Endosomes; HSP70 heat shock proteins; Huntington disease; Lysosome

Indexed keywords

HEAT SHOCK PROTEIN 70; HUNTINGTIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOSOME; IMMUNOCYTOCHEMISTRY; LYSOSOME; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

EID: 33847643286     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2007.5     Document Type: Article

References (55)

1. Becher MW, Ross CA. Intranuclear neuronal inclusions in DRPLA. Mov Disord 1998;13:852-3
2. Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P, Deglon N, Brouillet E. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell. 2006;17:1652-63
3. Chai Y, Koppenhafer SL, Bonini NM, Paulson HL. Analysis of the role of heat shock protein (hsp) molecular chaperones in polyglutamine disease. J Neurosci 1999;19:10338-47
4. Chan HY, Warrick JM, Gray-Board GL, Paulson HL, Bonini NM. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum Mol Genet 2000;9:2811-20
5. Chuang JZ, Zhou H, Zhu M, Li SH, Li XJ, Sung CH. Characterization of a brain-enriched chaperone, MRJ, that inhibits huntingtin aggregation and toxicity independently. J Biol Chem 2002;277:19831-8
6. Cooper JK, Schiling G, Peters MF, Herring WJ, Sharp AH, Kaminsky Z, Masone J, Khan FA, Delanoy M, Borchelt DR. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet 1998;7:783-90
7. Davies SW, Turmain M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. Formation of neuronal intranuclear inclusion underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997;9:537-48
8. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonstattel JP, Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophin neurites in brain. Science 1997;277:1990-3
9. Han MK, Kim M, Bae SY, Kang L, Han SY, Lee YS, Rha JH, Kim SU, Roh JK. VEGF protects human cerebral hybrid neurons from in vitro ischemia. Neuroreport 2004;15:847-50
10. Hansson O, Nylandsted J, Castilho RF, Leist M, Jaattela M, Brundin P. Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression. Brain Res 2003;970:47-57
11. Hay SA, Dice JF. Roles of molecular chaperones in protein degradation. J Cell Biol 1996;132:255-8
12. Holmberg M, Duyckaerts C, Durr A, Cancel G, Gourfinkel-An I, Damier P, Faucheux B, Trottier Y, Hirsch EC, Agid Y, Brice A. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 1998;7:913-8
13. Ide K, Nukina N, Masuda N, Goto J, Kanazawa I. Abnormal gene product identified in Huntington's disease lymphocytes and brain. Biochem Biophys Res Commun 1995;209:1119-25
14. Jaattela M, Wissing D, Kokholm K, Kallunki T, Egeblad M. HSP70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J 1998;17:6124-34
15. Jana NR, Tanaka M, Wang G, Nukina N. Polyglutamine length-dependent interaction of HSP40 and HSP70 family chaperones with truncated N-terminal huntingtin: their role in suppression of and cellular toxicity. Hum Mol Genet 2000;9:2009-18
16. Kegel KB, Kim M, Sapp E, McIntyre C, Castano JG, Aronin N, DiFiglia M. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci 2000;20:7268-78
17. Kim M, Lee HS, LaForet G, Mclnytyre C, Martin EJ, Chang P, Kim TW, Wolliams M, Reddy PH, Tagle D, Boyce FM, Won L, Heller A, Aronin N, DiFiglia M. Mutant huntingtin expression in clonal striatal cells : Dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci 1999;19:964-73
18. Kim M, Roh JK, Yoon BW, Kang LM, Kim YJ, Aronin N, DiFiglia M. Huntington is degraded to small fragments by calpain after ischemic injury. Experimental Neurology 2003;183:109-15
19. Kim YJ, Sapp E, Cuiffo BG, Sobin L, Yoder J, Kegel KB, Qin ZH, Detloff P, Aronin N, DiFiglia M. Lysosomal proteases are involved in generation of N-terminal huntingtin fragments. Neurobiol Dis 2006;22:346-56
20. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB, Zoghbi HY, Orr HT. Ataxin-1 nuclear localization and aggregation : role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 1998;95:41-53
21. Krobitsch S, Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. PNAS 2000;97:1589-4
22. Lee SH, Kim M, Kim YJ, Kim YA, Chi JG, Roh JK, Yoon BW. Ischemic intensity influences the distribution of delayed infarction and apoptotic cell death following transient focal cerebral ischemia in rats. Brain Res 2002;956:14-23
23. Lesperance MM, Hall JW 3rd, Bess FH, Fukushima K, Jain PK, Ploplis B, San Agustin TB, Skarka H, Smith RJ, Wills M. A gene for autosomal dominant nonsyndromic hereditary hearing impairment maps to 4p16.3. Hum Mol Genet 1995;4:1967-72
24. Li M, Miwa S, Kobayashi Y, Merry DE, Yamamoto M, Tanaka F, Doyu M, Hashizume Y, Fischbeck KH, Sobue G. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol 1998;44:249-54
25. Li SH, Cheng AL, Li H, Li XJ. Cellular defects and altered gene expression PC12 cells stably expressing mutant huntingtin. J Neurosci 1999;19:5159-72
26. MacDonald ME, Ambrose C, Duyao MP, Myers RH, Lin C, Srinidhi L et al., The Huntington's Disease Collaborative Research Group. A novel gene containing a trinudeotide repeat that is exparded and unstable on Huntington's disease chromosmes. Cell 1993;72:971-83
27. Muchowski PJ, Schaffar G, Sittler A, Wanker EE, Hayer-Hartl MK, Hartl FU. HSP70 and HSP40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. PNAS 2000;97:7841-6
28. Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995;81:811-23
29. Novoselova TV, Margulis BA, Novoselov SS, Sapozhnikov AM, van der Spuy J, Cheetham ME, Guzhova IV. Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation. J Neurochem 2005;94:597-606
30. Pal A, Severin F, Lommer B, Shevchenko A, Zerial M. Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease. J Cell Biol 2006;172:605-18
31. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997;19:333-44
32. Perutz MF. Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem Sci 1999;24:58-63
33. Qin ZH, Wang Y, Kegel KB, Kazantsev A, Apostol BL, Thompson LM, Yoder J, Aronin N, DiFiglia M. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet 2003;12:3231-44
34. Qin ZH, Wang Y, Sapp E, Cuiffo B, Wanker E, Hayden MR, Kegel KB, Aronin N, DiFiglia M. Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J Neurosci 2004;24:269-81
35. Reddy PS, Housman DE. The complex pathology of trinucleotide repeats. Curr Opin Cell Biol 1997;9:364-72
36. Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C, Clementi E, Hackam A, Hayden MR, Li Y, Cooper JK, Ross CA, Govoni S, Vincenz C, Cattaneo E. Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 2000;20:3705-17
37. Ross CA, Margolis RL, Rossenblatt A, Ranen NG, Becher MW, Aylward EA. Review in molecular medcin: Huntington's disease and a related disorder, dentatorubarl-pallidolusian atrophy (DRPLA). Medicine 1997;76:305-38
38. Rubinsztein DC, Wyttenbach A, Rankin J. Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts? J Med Genet 1999;36:265-70
39. Rubinsztein DC, Difiglia M, Heintz N, Nixon RA, Qin ZH, Ravikumar B, Stefanis L, Tolkovsky A. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 2005;1:11-22
40. Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M. Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 1997;42:604-12
41. Scheibel T, Buchner J. Protein aggregation as a cause for disease. Handb Exp Pharmacol 2006;199-219
42. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Bathes GP, Davies SW, Lehrach H, Wanker EE. Huntingtin-encoded polyglutamine expansion from amyloid-like protein aggregates in vitro and in vivo. Cell 1997;90:549-58
43. Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995;14:1065-74
44. Skinner PJ, Koshy BT, Cummings CJ, Klement IA, Helin K, Servadio A, Zoghbi HY, Orr HT. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997;389:971-4
45. Suopanki J, Gotz C, Lutsch G, Schiller J, Harjes P, Herrmann A, Wanker EE. Interaction of huntingtin fragments with brain membranes-clues to early dysfunction in Huntington's disease. J Neurochem 2006;96:870-84
46. Vacher C, Garcia-Oroz L, Rubinsztein DC. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. Hum Mol Genet 2005;14:3425-33
47. Waelter S, Boeddrich A, Lurz R, Scherzinger E, Lueder G, Lehrach H, Wanker EE. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell 2001;12:1393-407
48. Warrick JM, Chan HYE, Gray-Hoard GL, Chai Y, Paulson HL, Bonini NM. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nature Genet 1999;23:425-8
49. Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K, Salvesen GS, Propp SS, Bromm M, Rowland KJ, Zhang T, Rasper D, Roy S, Thornberry N, Pinsky L, Kakizuka A, Ross CA, Nicholson DW, Bredesen DE, Hayden MR. Caspase cleavage of gene products associated with triplet expansion disorder generates truncated fragments containing the polyglutamine tract. J Bio Chem 1998;273:9158-67
50. Wojcik C. An inhibitor of the chymotrypsin-like activity of the proteasome (PSI) induces similar morphological changes in various cell lines. Folia Histochem Cytobiol 1997;35:211-4
51. Wyttenbach A, Carmichael J, Swartz J, Furlong RA, Narain Y, Rankin J, Rubinsztein DC. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. PNAS 2000;14:2898-903
52. Wyttenbach A, Sauvageot O, Carmichael J, Diaz-Latoud C, Arrigo AP, Rubinsztein DC. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum Mol Genet 2002;11:1137-51
53. Yenari MA, Giffard RG, Sapolsky RM, Steinberg GK. The neuroprotective potential of heat shock protein 70 (HSP70). Mol Med Today 1999;5:525-31
54. Zala D, Benchoua A, Brouillet E, Perrin V, Gaillard MC, Zurn AD, Aebischer P, Deglon N. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiol Dis 2005;20:785-98
55. Zhou H, Li SH, Li XJ. Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation. J Biol Chem 2001;276:48417-24